Top

Cancer Causes & Control

Published in:

01-10-2009 | Original paper

Lifestyle factors, obesity and the risk of colorectal adenomas in EPIC-Heidelberg

Authors: Silke Hermann, Sabine Rohrmann, Jakob Linseisen

Published in: Cancer Causes & Control | Issue 8/2009

Abstract

Objective

We investigated the association of lifestyle and obesity with colorectal adenoma risk in a prospective setting.

Methods

At recruitment (1994–1998), information on diet, anthropometry, lifestyle, and medication was assessed in 25,540 participants of the EPIC-Heidelberg cohort. Until June 2007, 536 verified incident colorectal adenomas were identified. Furthermore, participants with negative colonoscopy (n = 3966) were included in the analytic cohort.

Results

In multivariate logistic regression analyses, participants with highest alcohol intake had an increased adenoma risk (odds ratio [OR] = 1.63; 95% CI 1.21–2.22) compared with lowest intake group. Folate consumption modified the ethanol effect (p-interaction = 0.03). Current smokers had a significantly increased adenoma risk compared with never smokers (OR = 1.40; 95% CI 1.16–1.84). Regular NSAID intake was associated with lower risk in subjects who reported their use at least twice compared with nonusers (OR = 0.70; 95% CI 0.53–0.93). Physical activity, body mass index, and waist-to-hip ratio were not consistently associated with adenoma risk.

Conclusions

The results of this prospective cohort study showed that alcohol intake and smoking are important risk factors for colorectal adenoma, and regular NSAID use decreases the risk. The relationship between alcohol consumption and adenoma risk was modified by folate intake. However, we could not confirm an effect of obesity or physical activity on adenoma risk.

Neugut AI, Garbowski GC, Lee WC et al (1993) Dietary risk factors for the incidence and recurrence of colorectal adenomatous polyps. A case–control study. Ann Intern Med 118:91–95PubMed

Ferlay J, Bray F, Pisani P, Parkin D (2002) GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC Press, Lyon

Botteri E, Iodice S, Raimondi S, Maisonneuve P, Lowenfels AB (2008) Cigarette smoking and adenomatous polyps: a meta-analysis. Gastroenterology 134:388–395. doi:10.1053/j.gastro.2007.11.007 PubMedCrossRef

Martin C, Connelly A, Keku TO et al (2002) Nonsteroidal anti-inflammatory drugs, apoptosis, and colorectal adenomas. Gastroenterology 123:1770–1777. doi:10.1053/gast.2002.37053 PubMedCrossRef

Hartman TJ, Yu B, Albert PS et al (2005) Does nonsteroidal anti-inflammatory drug use modify the effect of a low-fat, high-fiber diet on recurrence of colorectal adenomas? Cancer Epidemiol Biomarkers Prev 14:2359–2365. doi:10.1158/1055-9965.EPI-05-0333 PubMedCrossRef

Miller EA, Keku TO, Satia JA, Martin CF, Galanko JA, Sandler RS (2007) Calcium, dietary, and lifestyle factors in the prevention of colorectal adenomas. Cancer 109:510–517. doi:10.1002/cncr.22453 PubMedCrossRef

Lieberman DA, Prindiville S, Weiss DG, Willett W (2003) Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA 290:2959–2967. doi:10.1001/jama.290.22.2959 PubMedCrossRef

Ashktorab H, Begum R, Akhgar A et al (2007) Folate status and risk of colorectal polyps in African Americans. Dig Dis Sci 52:1462–1470. doi:10.1007/s10620-006-9236-8 PubMedCrossRef

Morimoto LM, Newcomb PA, Ulrich CM, Bostick RM, Lais CJ, Potter JD (2002) Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential? Cancer Epidemiol Biomarkers Prev 11:1012–1018PubMed

10.

Giovannucci E, Stampfer MJ, Colditz GA et al (1993) Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst 85:875–884. doi:10.1093/jnci/85.11.875 PubMedCrossRef

11.

Toyomura K, Yamaguchi K, Kawamoto H et al (2004) Relation of cigarette smoking and alcohol use to colorectal adenomas by subsite: the self-defense forces health study. Cancer Sci 95:72–76. doi:10.1111/j.1349-7006.2004.tb03173.x PubMedCrossRef

12.

Martinez ME, McPherson RS, Annegers JF, Levin B (1995) Cigarette smoking and alcohol consumption as risk factors for colorectal adenomatous polyps. J Natl Cancer Inst 87:274–279. doi:10.1093/jnci/87.4.274 PubMedCrossRef

13.

Cope GF, Wyatt JI, Pinder IF, Lee PN, Heatley RV, Kelleher J (1991) Alcohol consumption in patients with colorectal adenomatous polyps. Gut 32:70–72. doi:10.1136/gut.32.1.70 PubMedCrossRef

14.

Olsen J, Kronborg O (1993) Coffee, tobacco and alcohol as risk factors for cancer and adenoma of the large intestine. Int J Epidemiol 22:398–402. doi:10.1093/ije/22.3.398 PubMedCrossRef

15.

Breuer-Katschinski B, Nemes K, Marr A et al (2000) Alcohol and cigarette smoking and the risk of colorectal adenomas. Dig Dis Sci 45:487–493. doi:10.1023/A:1005432804902 PubMedCrossRef

16.

Erhardt JG, Kreichgauer HP, Meisner C, Bode JC, Bode C (2002) Alcohol, cigarette smoking, dietary factors and the risk of colorectal adenomas and hyperplastic polyps—a case control study. Eur J Nutr 41:35–43. doi:10.1007/s003940200004 PubMedCrossRef

17.

Benito E, Cabeza E, Moreno V, Obrador A, Bosch FX (1993) Diet and colorectal adenomas: a case–control study in Majorca. Int J Cancer 55:213–219. doi:10.1002/ijc.2910550208 PubMedCrossRef

18.

Shrubsole MJ, Wu H, Ness RM, Shyr Y, Smalley WE, Zheng W (2008) Alcohol drinking, cigarette smoking, and risk of colorectal adenomatous and hyperplastic polyps. Am J Epidemiol 167:1050–1058. doi:10.1093/aje/kwm400 PubMedCrossRef

19.

Riboli E, Cornee J, Macquart-Moulin G, Kaaks R, Casagrande C, Guyader M (1991) Cancer and polyps of the colorectum and lifetime consumption of beer and other alcoholic beverages. Am J Epidemiol 134:157–166PubMed

20.

Hoshiyama Y, Kono S, Sasaba T, Shigematsu T, Kawaguchi T (2000) Relation of cigarette smoking, alcohol use, and dietary habits to colon adenomas: a case–control study in Saitama, Japan. Asian Pac J Cancer Prev 1:139–146PubMed

21.

Stemmermann GN, Heilbrun LK, Nomura AM (1988) Association of diet and other factors with adenomatous polyps of the large bowel: a prospective autopsy study. Am J Clin Nutr 47:312–317PubMed

22.

Giovannucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, Willett WC (1995) Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med 122:327–334PubMed

23.

Boutron-Ruault MC, Senesse P, Meance S, Belghiti C, Faivre J (2001) Energy intake, body mass index, physical activity, and the colorectal adenoma-carcinoma sequence. Nutr Cancer 39:50–57. doi:10.1207/S15327914nc391_7 PubMedCrossRef

24.

Giovannucci E, Colditz GA, Stampfer MJ, Willett WC (1996) Physical activity, obesity, and risk of colorectal adenoma in women (United States). Cancer Causes Control 7:253–263. doi:10.1007/BF00051301 PubMedCrossRef

25.

Sedjo RL, Byers T, Levin TR et al (2007) Change in body size and the risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 16:526–531. doi:10.1158/1055-9965.EPI-06-0229 PubMedCrossRef

26.

Rosenberg L, Boggs D, Wise LA et al (2006) A follow-up study of physical activity and incidence of colorectal polyps in African–American women. Cancer Epidemiol Biomarkers Prev 15:1438–1442. doi:10.1158/1055-9965.EPI-06-0079 PubMedCrossRef

27.

Bohlscheid-Thomas S, Hoting I, Boeing H, Wahrendorf J (1997) Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the German part of the EPIC project. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 26 (Suppl 1):S59-70. doi:10.1093/ije/26.suppl_1.S59

28.

Wareham NJ, Jakes RW, Rennie KL et al (2003) Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr 6:407–413. doi:10.1079/PHN2002439 PubMedCrossRef

29.

Boutron MC, Faivre J, Dop MC, Quipourt V, Senesse P (1995) Tobacco, alcohol, and colorectal tumors: a multistep process. Am J Epidemiol 141:1038–1046PubMed

30.

International Agency for Research on Cancer (IARC) (1999) Lyon: World Health Organization. IARC Monographs on the Evaluation of the carcinogenic risk of chemicals to humans: re-evaluation of some organic chemicals, hydrazine and hydrogen peroxide (part two)

31.

GA SeitzHK, Lieber CS (1981) Enhanced pulmonary and intestinal activation of procarcinogens and mutagens after chronic ethanol consumption in the rat. Eur J Clin Invest 11:33–38. doi:10.1111/j.1365-2362.1981.tb01762.x CrossRef

32.

Cs L (2004) The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role. Drug Metab Rev 36:511–529. doi:10.1081/DMR-200033441 CrossRef

33.

Bergheim I, Parlesak A, Dierks C, Bode JC, Bode C (2003) Nutritional deficiencies in German middle-class male alcohol consumers: relation to dietary intake and severity of liver disease. Eur J Clin Nutr 57:431–438. doi:10.1038/sj.ejcn.1601557 PubMedCrossRef

34.

Giovannucci E (2002) Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr 132:2350S–2355SPubMed

35.

Boyapati SM, Bostick RM, McGlynn KA et al (2004) Folate intake, MTHFR C677T polymorphism, alcohol consumption, and risk for sporadic colorectal adenoma (United States). Cancer Causes Control 15:493–501. doi:10.1023/B:CACO.0000036447.45446.2c PubMedCrossRef

36.

Kenyon SH, Nicolaou A, Gibbons WA (1998) The effect of ethanol and its metabolites upon methionine synthase activity in vitro. Alcohol 15:305–309. doi:10.1016/S0741-8329(97)00134-1 PubMedCrossRef

37.

Purohit V, Khalsa J, Serrano J (2005) Mechanisms of alcohol-associated cancers: introduction and summary of the symposium. Alcohol 35:155–160. doi:10.1016/j.alcohol.2005.05.001 PubMedCrossRef

38.

Pufulete M, Al-Ghnaniem R, Khushal A et al (2005) Effect of folic acid supplementation on genomic DNA methylation in patients with colorectal adenoma. Gut 54:648–653. doi:10.1136/gut.2004.054718 PubMedCrossRef

39.

Giovannucci E, Chen J, Smith-Warner SA et al (2003) Methylenetetrahydrofolate reductase, alcohol dehydrogenase, diet, and risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 12:970–979PubMed

40.

Wolf LA, Terry PD, Potter JD, Bostick RM (2007) Do factors related to endogenous and exogenous estrogens modify the relationship between obesity and risk of colorectal adenomas in women? Cancer Epidemiol Biomarkers Prev 16:676–683. doi:10.1158/1055-9965.EPI-06-0883 PubMedCrossRef

41.

Pischon T, Lahmann PH, Boeing H et al (2006) Body size and risk of colon and rectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 98:920–931PubMedCrossRef

42.

Lubin F, Rozen P, Arieli B et al (1997) Nutritional and lifestyle habits and water-fiber interaction in colorectal adenoma etiology. Cancer Epidemiol Biomarkers Prev 6:79–85PubMed

43.

Kono S, Shinchi K, Ikeda N, Yanai F, Imanishi K (1991) Physical activity, dietary habits and adenomatous polyps of the sigmoid colon: a study of self-defense officials in Japan. J Clin Epidemiol 44:1255–1261. doi:10.1016/0895-4356(91)90158-6 PubMedCrossRef

44.

Hauret KG, Bostick RM, Matthews CE et al (2004) Physical activity and reduced risk of incident sporadic colorectal adenomas: observational support for mechanisms involving energy balance and inflammation modulation. Am J Epidemiol 159:983–992. doi:10.1093/aje/kwh130 PubMedCrossRef

45.

Terry MB, Neugut AI, Bostick RM et al (2002) Risk factors for advanced colorectal adenomas: a pooled analysis. Cancer Epidemiol Biomarkers Prev 11:622–629PubMed

46.

Neugut AI, Terry MB, Hocking G et al (1996) Leisure and occupational physical activity and risk of colorectal adenomatous polyps. Int J Cancer 68:744–748. doi:10.1002/(SICI)1097-0215(19961211)68:6<744::AID-IJC9>3.0.CO;2-3 PubMedCrossRef

47.

Wallace K, Baron JA, Karagas MR et al (2005) The association of physical activity and body mass index with the risk of large bowel polyps. Cancer Epidemiol Biomarkers Prev 14:2082–2086. doi:10.1158/1055-9965.EPI-04-0757 PubMedCrossRef

48.

Bartram HP, Wynder EL (1989) Physical activity and colon cancer risk? Physiological considerations. Am J Gastroenterol 84:109–112PubMed

49.

Garcia Rodriguez LA, Huerta-Alvarez C (2000) Reduced incidence of colorectal adenoma among long-term users of nonsteroidal antiinflammatory drugs: a pooled analysis of published studies and a new population-based study. Epidemiology 11:376–381. doi:10.1097/00001648-200007000-00003 PubMedCrossRef

50.

Tangrea JA, Albert PS, Lanza E et al (2003) Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States). Cancer Causes Control 14:403–411. doi:10.1023/A:1024990617158 PubMedCrossRef

51.

Baron JA (2003) Epidemiology of non-steroidal anti-inflammatory drugs and cancer. Prog Exp Tumor Res 37:1–24. doi:10.1159/000071364 PubMedCrossRef

52.

Logan RF, Grainge MJ, Shepherd VC, Armitage NC, Muir KR (2008) Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Gastroenterology 134:29–38. doi:10.1053/j.gastro.2007.10.014 PubMedCrossRef

53.

Thun MJ, Henley SJ, Patrono C (2002) Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 94:252–266PubMed

54.

Huls G, Koornstra JJ, Kleibeuker JH (2003) Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas. Lancet 362:230–232. doi:10.1016/S0140-6736(03)13915-3 PubMedCrossRef

55.

Sansbury LB, Bergen AW, Wanke KL et al (2006) Inflammatory cytokine gene polymorphisms, nonsteroidal anti-inflammatory drug use, and risk of adenoma polyp recurrence in the polyp prevention trial. Cancer Epidemiol Biomarkers Prev 15:494–501. doi:10.1158/1055-9965.EPI-05-0763 PubMedCrossRef

56.

Martinez ME, O’Brien TG, Fultz KE et al (2003) Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene. Proc Natl Acad Sci USA 100:7859–7864. doi:10.1073/pnas.1332465100 PubMedCrossRef

57.

Wu K, Giovannucci E, Byrne C (2006) Meat mutagens and risk of distal colon adenoma in a cohort of US men. Cancer Epidemiol Biomarkers Prev 15:1120–1125. doi:10.1158/1055-9965.EPI-05-0782 PubMedCrossRef

Title: Lifestyle factors, obesity and the risk of colorectal adenomas in EPIC-Heidelberg
Authors: Silke Hermann
Sabine Rohrmann
Jakob Linseisen
Publication date: 01-10-2009
Publisher: Springer Netherlands
Published in: Cancer Causes & Control / Issue 8/2009
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-009-9366-3

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Objective

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 8/2009

Dietary vitamin C, E, and carotenoid intake and risk of renal cell carcinoma

Relationship between interferon regulatory factor 4 genetic polymorphisms, measures of sun sensitivity and risk for non-Hodgkin lymphoma

Effect of COX2 -765G>C and c.3618A>G polymorphisms on the risk and survival of sporadic colorectal cancer

Ionizing radiation: a risk factor for mesothelioma

Socioeconomic status and prostate cancer incidence and mortality rates among the diverse population of California

Timing of births and endometrial cancer risk in Swedish women

Keynote webinar | Spotlight on antibody–drug conjugates in cancer